Labishetty Sai Charan
Also known as: Sai Charan L
Chandigarh University, NIMS University, UNIVERSITY OF HYDERABAD, GALGOTIAS UNIVERSITY
About
Labishetty Sai Charan, currently serving as Assistant Professor and Head of the Department of Optometry at the University Institute of Allied Health Sciences, Chandigarh University, India. I am a PhD scholar at NIMS University, Jaipur, where my doctoral research focuses on evaluating myopia treatment strategies and their efficacy. My academic and research journey is rooted in the pursuit of improving visual health outcomes through scientific precision, clinical insight, and evidence-based innovation.
My research interests encompass myopia control, ocular anatomical changes, binocular vision, contact lens science, and low vision rehabilitation. I am particularly passionate about developing and validating practical, patient-centered approaches to manage progressive myopia using pharmacological, optical, and behavioral interventions. As an educator and researcher, I strive to inspire critical thinking, mentor emerging optometrists, and build interdisciplinary collaborations that advance the science and clinical practice of optometry in India and beyond.
Employment
-
Chandigarh University Head of Department & Assistant Professor2022 - Present
-
NIMS University Research Scholar2021 - Present
-
GALGOTIAS UNIVERSITY ASSISTANT PROFESSOR2017 - 2022
-
LAWERENCE AND MAYO CONSULTANT OPTOMETRIST2016 - 2017
Education
-
UNIVERSITY OF HYDERABAD I.M.Sc OPTOMETRY AND VISION SCIENCES2011 - 2016
-
NIMS University Ph.D
Projects & Funding
Projects & funding information is unavailable.
Publications (26)
- Bridging the gap: The role of collaborative care in pre-operative dry eye assessment Save
- OPTOMETRIC EVIDENCE IN FORENSIC SCIENCE: THE ROLE OF OCULAR TRAUMA AND RETINAL HEMORRHAGES IN CRIMINAL INVESTIGATIONS Save
- OPTOMETRIC EVIDENCE IN FORENSIC SCIENCE: THE ROLE OF OCULAR TRAUMA AND RETINAL HEMORRHAGES IN CRIMINAL INVESTIGATIONS Save
- Nano-Patterned Wetting Layers on Silicone Hydrogels: Toward Continuous-Wear Contact Lenses with Enhanced Oxygen Flux Save
- Functional Safety and Efficacy of 0.01% Atropine for Myopia Control in Adolescents: An 18-Month Double-Masked Randomized Controlled Trial Save
- From forensic medical databases to court-defensible artificial intelligence: the next translational step is standards, not scale Save
- Beyond depolymerization rates: Health‑aligned benchmarking for PET‑degrading enzymes in enzyme and microbial technology Save
- A Review on Correlation Between Autorefractometer and Cycloplegic Refraction with Subjective Acceptance in Children Aged 6-15 Years Save
- Comment on morning administration is more effective than evening administration of 0.01% atropine with orthokeratology for myopia control Save
- Comment on “Conjunctival microbiota in retinal diseases requiring anti-VEGF therapy: Age-related macular degeneration, diabetic retinopathy, and retinal vein occlusion” Save